Stanford, StartX Fund awardee, grabs $2m seed round
Nirmidas Biotech, Inc., a diagnostic research technology company, is announcing that it has raised $2 million in seed round funding to commercialize its fluorescence enhancing plasmonic gold technology, called “pGOLD.” The technology platform, which significantly boosts the ability to detect disease biomarkers, is based on nearly a decade of research at Stanford University and is […]